An application of ERBB2 receptor inhibitors in a rare case of S310F somatic ERBB2 mutation of primary signet-ring cell adenocarcinoma of vagina: A case report and review literature of S310F somatic ERBB2 mutation in breast and gynecologic cancers
Main Authors: | June Y. Hou, Jason D. Wright, Vuthinun Achariyapota |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920300436 |
Similar Items
-
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01) -
Activating mutations in ERBB2 and their impact on diagnostics and treatment
by: Grit Sophie Herter-Sprie, et al.
Published: (2013-04-01) -
ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report
by: Michele Minuto, et al.
Published: (2018-04-01) -
Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
by: Andrew J. Shih, et al.
Published: (2011-03-01) -
Targeting ERBB2 mutations in solid tumors: biological and clinical implications
by: Sophie Cousin, et al.
Published: (2018-06-01)